IPATH Scientific Reports

A retrospective, observational study of 12 cases of expanded access customized phage therapy: production, characteristics, and clinical outcomes
Clinical Infectious Diseases | June 3, 2023

Therapeutic Potential of Intravenous Phage as Standalone Therapy for Recurrent Drug-Resistant Urinary Tract Infections
Antimicrobial Agents and Chemotherapy | March 28, 2023

Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia
Journal of Infectious Diseases | February 1, 2023

Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease
Clinical Infectious Diseases | January 6, 2023

Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection
Nature Communications | May 3, 2022

Comparative genomics of Acinetobacter baumannii and therapeutic bacteriophages from a patient undergoing phage therapy
Nature Communications | June 30, 2022

Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation
Viruses | September 7, 2021

Successful Treatment of Staphylococcus aureus Prosthetic Joint Infection with Bacteriophage Therapy
Viruses | June 21, 2021

Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection
Microbiome | April 14, 2021

Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection
Viruses | October 12, 2021

Lessons Learned from First Ten Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug Resistant Bacterial Infections at a Single Center in the US
Open Forum Infectious Diseases | August 27, 2020

Novel bacteriophage therapy for treatment of left ventricular assist device infection
The Journal of Heart and Lung Transplantation | April 2019

Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient
Infection | August 2019

Early clinical experience of bacteriophage therapy in three lung transplant recipients
American Journal of Transplantation | September, 2019

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
Nature Medicine | May 8, 2019

Successful treatment of antibiotic resistant poly-microbial bone infection with bacteriophages and antibiotics combination
Clinical Infectious Diseases | November 13, 2019

Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
Open Forum Infectious Diseases | March 23, 2018

Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection
Antimicrobial Agents and Chemotherapy | September 22, 2017

Exploring bacteriophage therapy for drug-resistant bacterial infections.
Topics in Antiviral Medicine | March 31, 2023

Phage therapy: From biological mechanisms to future directions
Cell Review | January 5, 2023

Role of bacteriophage therapy for resistant infections in transplant recipients
Current Opinion in Organ Transplantation | December 1, 2022

Phage Therapy for Antibiotic-Resistant Bacterial Infections
Annual Review of Medicine | January 27, 2022

Considerations for the Use of Phage Therapy in Clinical Practice
Antimicrobial Agents and Chemotherapy | March 15, 2022

Phage Therapy: Primer and Role in the Treatment of MDROs
Current Infectious Disease Reports | November 13, 2020

Bacteriophage therapy as a treatment option for transplant infections
Current Opinion in Infectious Diseases | August 2020

Treat phage like living antibiotics
Nature Microbiology | February 26, 2020

What's Old Is New Again: Bacteriophage Therapy in the 21st Century
Antimicrobial Agents and Chemotherapy | December 20, 2019

Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy
Current Opinion in Microbiology | October 2019

Isolation of a Peptide That Binds to Pseudomonas aeruginosa Lytic Bacteriophage
ACS Omega | October 12, 2022

Increased Innate Immune Susceptibility in Hyperpigmented Bacteriophage-Resistant Mutants of Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy | August 16, 2022

Phage Cocktails Constrain the Growth of Enterococcus
mSystems | August 30, 2022

Animal Models of Phage Therapy
Frontiers in Microbiology | January 28, 2021